The Denver Post

Herpes can be devastatin­g. To many doctors, it’s low priority

- By Dani Blum

When Lauren went to her doctors with stinging clusters of sores on her genitals, she assumed the pain was from a urinary tract infection. But at the OB- GYN, her doctor swabbed the bumps and told her that the rash was herpes. “No,” she remembered responding. “It’s not.”

At the time, Lauren, who asked that her last name be withheld in order to talk about personal health issues, was a 19-year- old college student. She was in a two-year monogamous relationsh­ip with her secondever sexual partner — a guy who occasional­ly dealt with an errant blister on his lip.

They hadn’t known that oral herpes could induce cold sores, and that HSV1, the virus that causes oral herpes, could be transferre­d to the genitals. Lauren’s boyfriend was convinced that she had cheated on him, and he broke up with her, she said.

Lauren became withdrawn and almost failed out of college. “You think, Why does anything even matter anymore?” she said. “I’m never going to date. I’m never going to have a boyfriend.”

That was in 2013. Over the past decade, Lauren has had only a few additional outbreaks, none as painful as her first. The mental strain — the depression she fell into after the diagnosis, the fear that future partners wouldn’t accept her — has been, by far, the hardest part of managing the disease. “It attacks your selfworth,” she said.

Herpes is extremely common: The World Health Organizati­on estimates that 3.7 billion people live with HSV-1, some oral and some genital. And cases like Lauren’s, where HSV-1 spreads to the genitals during oral sex, have sharply increased over the past two decades, said Dr. Jonathan Zenilman, a professor of medicine at Johns Hopkins University School of Medicine who specialize­s in sexually transmitte­d infections.

But herpes isn’t a top priority for researcher­s, said Dr. Larry Corey, a professor and virologist at Fred Hutch Cancer Center in Seattle who has studied the virus. It isn’t even the top priority among those who study sexually transmitte­d infections, he added. “The disease has been sort of ignored by both the pharma

ceutical industry as well as the medical research establishm­ent,” he said.

There are several potential reasons for this, experts theorize, including the relatively mild physical symptoms for most patients, clinicians’ reluctance to discuss sexual health and how hard it is to develop a vaccine for herpes.

“The fact that a lot of the toll is psychologi­cal makes physicians not that interested in it,” said Dr. Anna Wald, a clinical virologist and a professor of medicine at the University of Washington School of Medicine.

There has been little progress on more accurate tests, vaccines or additional treatments over the past few decades, Wald said. Part of the challenge is that the herpes virus can hide inside neurons that are shielded from the immune system, making the body’s immune response insufficie­nt at eradicatin­g the virus, she said — that’s why herpes remains in a person’s body for life. Vaccine attempts, so far, have not stimulated an immune response that can control the virus or prevent infection, she said.

If a patient does not have symptoms, doctors typically diagnose herpes with an antibody test that is frequently inaccurate. Up to half of positive commercial test results could be false, according to past research. There is another antibody test, called the herpes Western blot, that scientists consider the gold standard in diagnosing herpes — but the test is only available through the University of

Washington, which can be cumbersome and expensive for patients to obtain. Testing is typically reliable when a patient has symptoms; doctors can swab a lesion and run a highly sensitive molecular test.

The U.S. Preventive Services Task Force doesn’t recommend routine genital herpes screenings for people without symptoms, in part because false positive rates are so high. On Tuesday, the task force reaffirmed its recommenda­tion. In a related paper, a group of doctors wrote that the recommenda­tion was, in part, based on “psychosoci­al harms” associated with false positives on herpes tests.

And so the virus continues to spread essentiall­y unchecked — exacerbate­d by just how ineffectiv­e the most widely available tests for herpes are, said Terri Warren, a nurse practition­er who has researched herpes.

As cases circulate, patients are left grappling with a diagnosis that can be psychologi­cally devastatin­g, Zenilman said.

“You can control the symptoms,” he added. “But lots of people feel stigmatize­d, dirty.”

How herpes got sidelined

Herpes can be severe in certain cases: Babies can contract neonatal herpes from their mothers, putting them at risk for severe complicati­ons and even death. For people who are immunocomp­romised, outbreaks

can be more prolonged and painful. In the vast majority of cases, though, people will have very mild symptoms, and many will have none. That’s part of the reason the infection is so pervasive: People pass it onto partners without knowing they have herpes.

Those who contract HSV-1 may develop blisters on or around their mouths or, in some cases, on their genitals. HSV-2, the other predominan­t strain, is usually characteri­zed by one or more lesions around the genitals or the rectum. In the United States, around one in six people between the ages of 14 and 49 has genital herpes, and over half of adults have oral herpes.

Antiviral medication­s help reduce the amount of the virus a person sheds, lowering the chance that someone with herpes will pass it on to a sexual partner. Some patients take antivirals daily; others only take medication when they have an outbreak. But the risk of spreading herpes is never zero. The disease lingers in the body, putting the onus on patients to disclose their diagnosis to anyone with whom they have intimate contact.

When Lauren started dating after her diagnosis, she found herself staying in relationsh­ips for longer than she might otherwise, scared nobody else would want to be with her. “I thought I was going to die alone,” she said. Scientists have worked on herpes vaccines in fits and starts since the 1970s, said Dr. Harvey

Friedman, a professor of medicine at the University of Pennsylvan­ia Perelman School of Medicine who has studied the disease for more than 40 years. But past attempts have failed, for reasons researcher­s are still trying to uncover.

Because herpes has been around for so long, the viruses have evolved alongside us, making them more difficult to eradicate, said Christine Johnston, an associate professor at the University of Washington School of Medicine who has studied herpes.

There are new vaccines under developmen­t. Friedman is working with BionTech on an HSV-2 vaccine candidate that was given to the first human subject in December. But none are in late-stage clinical trials, said Dr. Ina Park, a professor of family and community medicine at the University of California, San Francisco, and author of “Strange Bedfellows: Adventures in the Science, History, and Surprising Secrets of STDS.” “There’s nothing anywhere close to prime time,” she said.

“One of the biggest secret societies”

When Ella Dawson, 30, contracted genital HSV-1 in college, she started to post openly about her diagnosis on social media. To her surprise, people came out of the woodwork to share their stories — friends, relatives, even a cashier who worked at the grocery store on campus. Many told her that they had never disclosed their diagnosis to anyone other than a sexual partner.

“It’s one of the biggest secret societies in the world,” said Dawson, a novelist and writer who often speaks publicly about her experience with herpes.

Courtney Brame, 34, started the herpes education advocacy organizati­on and podcast Something Positive for Positive People after his own HSV-2 diagnosis. He’s seen how the disease “completely shatters a person’s identity,” he said, partly because of how central sexuality can be to someone’s self-worth. “They don’t feel like they have anything to contribute to a relationsh­ip now, just because they have herpes,” he said. “It’s like, ‘ Who’s going to want me now that I have this?’”

Brame has seen this in his own life. He was once messaging a woman on Tinder who brought up her struggle with chronic asthma; when he disclosed his own chronic condition, she stopped responding. But more often than facing rejection, when he shares his diagnosis, he said, he gets a different response: Women share that they, too, have herpes.

Herpes stigma stems in part from the idea that people with the infection have done something “wrong,” Park said. But you can exercise every precaution and still get it, she added — condoms do not entirely prevent transmissi­on, and you don’t even need to have penetrativ­e sex to contract the virus.

Although condoms can reduce the risk of transmissi­on, not everyone with herpes will use a barrier method in long-term, monogamous relationsh­ips. In 2021, Something Positive for Positive People conducted a survey of more than 1,000 people diagnosed with herpes; around 66% said a partner had consented to sex without a condom or other barrier method. And there is little research on how the virus spreads between women who have sex with women, Park said.

Medical providers, in general, often don’t receive extensive education on talking to patients about sexual health, Johnston said. When it comes to herpes in particular, “health care providers can be really insensitiv­e about it and minimize it,” she said. “This is thought of more as a nuisance than a serious infection.”

 ?? SARA ANDREASSON — THE NEW YORK TIMES ?? Billions of people live with herpes, but there has been scant progress for treatments and tests.
SARA ANDREASSON — THE NEW YORK TIMES Billions of people live with herpes, but there has been scant progress for treatments and tests.

Newspapers in English

Newspapers from United States